
Medicare Announces First 10 Drugs for Price Negotiations
In a groundbreaking move aimed at alleviating the escalating burden of prescription drug costs, the US Department of Health and Human Services (HHS) has unveiled the first 10 drugs that Medicare will target for price reductions through negotiations with pharmaceutical companies. These landmark negotiations have the potential to reshape the healthcare landscape, making life-saving medications